CN114711374A - 酵纤复合营养素粉及其制备方法 - Google Patents
酵纤复合营养素粉及其制备方法 Download PDFInfo
- Publication number
- CN114711374A CN114711374A CN202210391800.5A CN202210391800A CN114711374A CN 114711374 A CN114711374 A CN 114711374A CN 202210391800 A CN202210391800 A CN 202210391800A CN 114711374 A CN114711374 A CN 114711374A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- mass
- yeast
- fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 96
- 239000000835 fiber Substances 0.000 title claims abstract description 50
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 30
- 239000002131 composite material Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 32
- 241000209140 Triticum Species 0.000 claims abstract description 27
- 235000021307 Triticum Nutrition 0.000 claims abstract description 26
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims abstract description 18
- 229940107187 fructooligosaccharide Drugs 0.000 claims abstract description 18
- 235000019895 oat fiber Nutrition 0.000 claims abstract description 18
- 229920001202 Inulin Polymers 0.000 claims abstract description 16
- 229940029339 inulin Drugs 0.000 claims abstract description 16
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 16
- 235000005976 Citrus sinensis Nutrition 0.000 claims abstract description 15
- 240000002319 Citrus sinensis Species 0.000 claims abstract description 15
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 15
- 229940088594 vitamin Drugs 0.000 claims abstract description 13
- 229930003231 vitamin Natural products 0.000 claims abstract description 13
- 235000013343 vitamin Nutrition 0.000 claims abstract description 13
- 239000011782 vitamin Substances 0.000 claims abstract description 13
- 239000000463 material Substances 0.000 claims abstract description 7
- 244000090599 Plantago psyllium Species 0.000 claims abstract description 6
- 235000010451 Plantago psyllium Nutrition 0.000 claims abstract description 6
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 34
- 239000011812 mixed powder Substances 0.000 claims description 33
- 238000002156 mixing Methods 0.000 claims description 33
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 26
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 22
- 238000007873 sieving Methods 0.000 claims description 21
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 18
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 18
- 239000008101 lactose Substances 0.000 claims description 18
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 17
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 17
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 17
- 235000005282 vitamin D3 Nutrition 0.000 claims description 16
- 239000011647 vitamin D3 Substances 0.000 claims description 16
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 16
- 229940021056 vitamin d3 Drugs 0.000 claims description 16
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 claims description 15
- 239000000832 lactitol Substances 0.000 claims description 14
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 claims description 14
- 229960003451 lactitol Drugs 0.000 claims description 14
- 235000010448 lactitol Nutrition 0.000 claims description 14
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 14
- 229940042585 tocopherol acetate Drugs 0.000 claims description 14
- 229960001763 zinc sulfate Drugs 0.000 claims description 14
- 229910000368 zinc sulfate Inorganic materials 0.000 claims description 14
- 244000134552 Plantago ovata Species 0.000 claims description 13
- 235000003421 Plantago ovata Nutrition 0.000 claims description 13
- 229920001100 Polydextrose Polymers 0.000 claims description 13
- 239000001259 polydextrose Substances 0.000 claims description 13
- 235000013856 polydextrose Nutrition 0.000 claims description 13
- 229940035035 polydextrose Drugs 0.000 claims description 13
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 12
- 235000019156 vitamin B Nutrition 0.000 claims description 12
- 239000011720 vitamin B Substances 0.000 claims description 12
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 11
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 11
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 11
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 claims description 11
- 235000019155 vitamin A Nutrition 0.000 claims description 11
- 239000011719 vitamin A Substances 0.000 claims description 11
- 229940045997 vitamin a Drugs 0.000 claims description 11
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 claims description 10
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 claims description 10
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 10
- 229960000304 folic acid Drugs 0.000 claims description 10
- 235000019152 folic acid Nutrition 0.000 claims description 10
- 239000011724 folic acid Substances 0.000 claims description 10
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 10
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims description 9
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 9
- 239000002211 L-ascorbic acid Substances 0.000 claims description 9
- 235000000069 L-ascorbic acid Nutrition 0.000 claims description 9
- 229960005070 ascorbic acid Drugs 0.000 claims description 9
- 235000000639 cyanocobalamin Nutrition 0.000 claims description 9
- 239000011666 cyanocobalamin Substances 0.000 claims description 9
- 229960004172 pyridoxine hydrochloride Drugs 0.000 claims description 9
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 claims description 9
- 239000011764 pyridoxine hydrochloride Substances 0.000 claims description 9
- 229960000342 retinol acetate Drugs 0.000 claims description 9
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 claims description 9
- 235000019173 retinyl acetate Nutrition 0.000 claims description 9
- 239000011770 retinyl acetate Substances 0.000 claims description 9
- 229960002477 riboflavin Drugs 0.000 claims description 9
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 claims description 9
- 239000001913 cellulose Substances 0.000 claims description 8
- 229920002678 cellulose Polymers 0.000 claims description 8
- 238000000227 grinding Methods 0.000 claims description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 8
- 235000010755 mineral Nutrition 0.000 claims description 8
- 239000011707 mineral Substances 0.000 claims description 8
- 235000019192 riboflavin Nutrition 0.000 claims description 8
- 239000002151 riboflavin Substances 0.000 claims description 8
- SRFKWQSWMOPVQK-UHFFFAOYSA-K sodium;2-[2-[bis(carboxylatomethyl)amino]ethyl-(carboxymethyl)amino]acetate;iron(2+) Chemical compound [Na+].[Fe+2].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O SRFKWQSWMOPVQK-UHFFFAOYSA-K 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 229960003080 taurine Drugs 0.000 claims description 7
- ONQGFDRKXIBIKP-RXSVEWSESA-N acetic acid;(2r)-2-[(1s)-1,2-dihydroxyethyl]-3,4-dihydroxy-2h-furan-5-one Chemical compound CC(O)=O.OC[C@H](O)[C@H]1OC(=O)C(O)=C1O ONQGFDRKXIBIKP-RXSVEWSESA-N 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229960001484 edetic acid Drugs 0.000 claims description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 4
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 239000008103 glucose Substances 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 3
- 229960003390 magnesium sulfate Drugs 0.000 claims description 3
- 235000003805 Musa ABB Group Nutrition 0.000 claims description 2
- 241001127637 Plantago Species 0.000 claims description 2
- 235000015266 Plantago major Nutrition 0.000 claims description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 229960002104 cyanocobalamin Drugs 0.000 claims description 2
- 229960001031 glucose Drugs 0.000 claims description 2
- 229960003966 nicotinamide Drugs 0.000 claims description 2
- 235000005152 nicotinamide Nutrition 0.000 claims description 2
- 239000011570 nicotinamide Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000011686 zinc sulphate Substances 0.000 claims 1
- 235000009529 zinc sulphate Nutrition 0.000 claims 1
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 235000013325 dietary fiber Nutrition 0.000 abstract description 12
- 238000010521 absorption reaction Methods 0.000 abstract description 11
- 230000006870 function Effects 0.000 abstract description 11
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract description 10
- 235000012000 cholesterol Nutrition 0.000 abstract description 4
- 150000001875 compounds Chemical class 0.000 abstract description 3
- 230000003871 intestinal function Effects 0.000 abstract description 2
- 108010028554 LDL Cholesterol Proteins 0.000 abstract 1
- 210000000577 adipose tissue Anatomy 0.000 abstract 1
- 239000003797 essential amino acid Substances 0.000 abstract 1
- 235000020776 essential amino acid Nutrition 0.000 abstract 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 abstract 1
- 241000220225 Malus Species 0.000 description 16
- 239000003925 fat Substances 0.000 description 16
- 235000019197 fats Nutrition 0.000 description 16
- 230000000968 intestinal effect Effects 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 230000015572 biosynthetic process Effects 0.000 description 13
- 235000002723 Dioscorea alata Nutrition 0.000 description 12
- 235000005362 Dioscorea floribunda Nutrition 0.000 description 12
- 235000004868 Dioscorea macrostachya Nutrition 0.000 description 12
- 235000005361 Dioscorea nummularia Nutrition 0.000 description 12
- 235000005360 Dioscorea spiculiflora Nutrition 0.000 description 12
- 235000004879 dioscorea Nutrition 0.000 description 12
- 235000018102 proteins Nutrition 0.000 description 11
- 108090000623 proteins and genes Proteins 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 230000009102 absorption Effects 0.000 description 10
- 235000013305 food Nutrition 0.000 description 9
- 230000004060 metabolic process Effects 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 235000016709 nutrition Nutrition 0.000 description 8
- 230000009286 beneficial effect Effects 0.000 description 7
- 230000012010 growth Effects 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 6
- 229930003268 Vitamin C Natural products 0.000 description 6
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 210000000936 intestine Anatomy 0.000 description 6
- 230000035764 nutrition Effects 0.000 description 6
- 235000014786 phosphorus Nutrition 0.000 description 6
- 239000011574 phosphorus Substances 0.000 description 6
- 229910052698 phosphorus Inorganic materials 0.000 description 6
- 235000019154 vitamin C Nutrition 0.000 description 6
- 239000011718 vitamin C Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 230000029087 digestion Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 230000037406 food intake Effects 0.000 description 5
- 235000012631 food intake Nutrition 0.000 description 5
- 210000001035 gastrointestinal tract Anatomy 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 235000020824 obesity Nutrition 0.000 description 5
- 230000036186 satiety Effects 0.000 description 5
- 235000019627 satiety Nutrition 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 4
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 4
- 238000009825 accumulation Methods 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 239000005515 coenzyme Substances 0.000 description 4
- 230000013872 defecation Effects 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 244000005700 microbiome Species 0.000 description 4
- 239000011701 zinc Substances 0.000 description 4
- 229910052725 zinc Inorganic materials 0.000 description 4
- 208000024172 Cardiovascular disease Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003571 Vitamin B5 Natural products 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 229960002079 calcium pantothenate Drugs 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 206010016256 fatigue Diseases 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000009200 high fat diet Nutrition 0.000 description 3
- 235000008085 high protein diet Nutrition 0.000 description 3
- 235000021070 high sugar diet Nutrition 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 230000037356 lipid metabolism Effects 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000035790 physiological processes and functions Effects 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- MKWYFZFMAMBPQK-UHFFFAOYSA-J sodium feredetate Chemical compound [Na+].[Fe+3].[O-]C(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O MKWYFZFMAMBPQK-UHFFFAOYSA-J 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 239000011691 vitamin B1 Substances 0.000 description 3
- 239000011675 vitamin B5 Substances 0.000 description 3
- 235000009492 vitamin B5 Nutrition 0.000 description 3
- 235000019159 vitamin B9 Nutrition 0.000 description 3
- 239000011727 vitamin B9 Substances 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 description 2
- FYGDTMLNYKFZSV-URKRLVJHSA-N (2s,3r,4s,5s,6r)-2-[(2r,4r,5r,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5r,6s)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1[C@@H](CO)O[C@@H](OC2[C@H](O[C@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-URKRLVJHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 229920002498 Beta-glucan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- 206010036618 Premenstrual syndrome Diseases 0.000 description 2
- 229930003761 Vitamin B9 Natural products 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 229960001231 choline Drugs 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 229960003692 gamma aminobutyric acid Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 230000002062 proliferating effect Effects 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000022558 protein metabolic process Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000019163 vitamin B12 Nutrition 0.000 description 2
- 239000011715 vitamin B12 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 208000037259 Amyloid Plaque Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N DL-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000002722 Dioscorea batatas Nutrition 0.000 description 1
- 235000007056 Dioscorea composita Nutrition 0.000 description 1
- 235000009723 Dioscorea convolvulacea Nutrition 0.000 description 1
- 235000006536 Dioscorea esculenta Nutrition 0.000 description 1
- 240000001811 Dioscorea oppositifolia Species 0.000 description 1
- 235000003416 Dioscorea oppositifolia Nutrition 0.000 description 1
- 206010013774 Dry eye Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- VTLYFUHAOXGGBS-UHFFFAOYSA-N Fe3+ Chemical compound [Fe+3] VTLYFUHAOXGGBS-UHFFFAOYSA-N 0.000 description 1
- 235000006350 Ipomoea batatas var. batatas Nutrition 0.000 description 1
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 208000031845 Pernicious anaemia Diseases 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 208000032400 Retinal pigmentation Diseases 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 208000020764 Sensation disease Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010047571 Visual impairment Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- NNXNKLLWTKSODZ-UHFFFAOYSA-N [acetyloxy-[2-(diacetyloxyamino)ethyl]amino] acetate;iron;sodium Chemical compound [Na].[Fe].CC(=O)ON(OC(C)=O)CCN(OC(C)=O)OC(C)=O NNXNKLLWTKSODZ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 201000003465 angular cheilitis Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000021407 appetite control Nutrition 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 230000000386 athletic effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000002308 calcification Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000007287 cheilitis Diseases 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003399 chemotactic effect Effects 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 239000000701 coagulant Substances 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000008094 contradictory effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 229940117373 dl-alpha tocopheryl acetate Drugs 0.000 description 1
- 229960003638 dopamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000037149 energy metabolism Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 208000037824 growth disorder Diseases 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 229910017053 inorganic salt Inorganic materials 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- -1 lipid compounds Chemical class 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007830 nerve conduction Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000008621 organismal health Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 210000001539 phagocyte Anatomy 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 230000033458 reproduction Effects 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 229940076279 serotonin Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 210000005239 tubule Anatomy 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L7/00—Cereal-derived products; Malt products; Preparation or treatment thereof
- A23L7/10—Cereal-derived products
- A23L7/115—Cereal fibre products, e.g. bran, husk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/10—Products from fruits or vegetables; Preparation or treatment thereof of tuberous or like starch containing root crops
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/14—Yeasts or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/25—Synthetic polymers, e.g. vinylic or acrylic polymers
- A23L33/26—Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开一种酵纤复合营养素粉及其制备方法，所述酵纤复合营养素粉包括主要成分和辅料，所述主要成分包括洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉。本发明的酵纤复合营养素粉可为人体提供必需氨基酸、膳食纤维、维生素等，降低人体血液中总胆固醇和低密度脂蛋白胆固醇的含量，调节肠道功能，增加人体吸收能力，从多方面调节人体机能，降低体脂含量。
Description
技术领域
本发明涉及食品技术领域，尤其涉及一种酵纤复合营养素粉及其制备方法。
背景技术
近年来，随着人们物质生活的不断提高，生活条件的日益优越，肥胖已经成为困扰全球身心健康的一种流行性疾病。不仅普通人群需要控制体重，一些重竞技等体育项目的运动员也需要控制体重。目前全世界的减肥方法主要有六种，其中运动减肥是首选有效的减肥方法，然而由于现代高效率快捷凑的现代生活使得人们很难抽出时间来履行；中医减肥疗程较长，难以坚持；手术减肥有着一定的手术风险和并发症等隐患；药物减肥其不良的副作用会破坏机体的体质健康；节食减肥会导致机体营养不良；营养配餐减肥方法繁琐、步骤复杂难以实施。食用营养代餐减肥成为一种新型、便捷、健康、有效的减肥方法，现有的营养代餐营养成分不太均衡，各个成分之间相互促进作用不强，针对身体个机能调节程度低，并且由于现代工业化生产精致食物，造成大量矿物质、维生素流失，以及各种食物纤维分离丢失，导致人体内纤维含量不足，严重缺乏肠道纤维，使肠道蠕动变弱，多余热量和毒素无法排出，消化系统菌群严重失衡。
因此，有必要提供一种新的食品以解决上述技术问题。
发明内容
本发明的主要目的是提供一种酵纤复合营养素粉及其制备方法，旨在提供一种新的食品以解决现有技术中各个成分之间相互促进作用不强，针对身体个机能调节程度低的技术问题。
为实现上述目的，本发明提出的酵纤复合营养素粉包括主要成分和辅料，所述主要成分包括洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉。
优选地，所述辅料包括复合维生素和矿物质。
优选地，所述复合维生素包括醋酸维生素A、L-抗坏血酸、胆钙化醇、 dl-α-醋酸生育酚和B族维生素。
优选地，所述B族维生素包括硝酸硫胺素、核黄素、烟酰胺、D-泛酸钙、盐酸吡哆醇、叶酸、氰钴胺。
优选地，所述矿物质包括硫酸锌和硫酸镁。
优选地，所述辅料还包括聚、乙二胺四乙酸铁钠、牛磺酸、葡萄糖、乳糖醇和异构化乳糖。
优选地，按质量份数计，所述洋车前子150～200质量份、所述燕麦纤维 150～200质量份、所述小麦纤维150～200质量份、所述小麦苗粉80～150质量份、所述山药粉100～150质量份、所述低聚果糖100～150质量份、所述苹果纤维100～150质量份、所述甜橙水果粉30～50质量份、所述酵母粉30～50质量份和所述菊粉80～150质量份。
优选地，按质量份数计，所述醋酸维生素A为1～5质量份、所述L-抗坏血酸为1～5质量份、所述胆钙化醇为1～5质量份、所述dl-α-醋酸生育酚为 1～5质量份和所述B族维生素为7～35质量份、所述硫酸锌为1～5质量份、所述硫酸镁为1～5质量份、所述乙二胺四乙酸铁钠为1～5质量份、所述牛磺酸为1～5质量份和所述聚葡萄糖为1～5质量份、乳糖醇为1～5质量份、异构化乳糖为1～5质量份。
本发明还提供了一种如上所述的酵纤复合营养素粉的制备方法，包括：
步骤一、将洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉过60-80目筛后混合均匀，得混合粉末a；
步骤二、将醋酸维生素A、L-抗坏血酸、胆钙化醇、dl-α-醋酸生育酚和 B族维生素过60-80目筛后混合均匀，得混合粉末b；
步骤三、将硫酸锌、硫酸镁和乙二胺四乙酸铁钠分别研磨，过60目筛后混合，搅拌均匀，得混合粉末c；
步骤四、将所述步骤一中制备的混合粉末a、所述步骤二中制备的混合粉末b、所述步骤三中制备的混合粉末c，并取聚葡萄糖、乳糖醇和异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。
本发明技术方案中，通过低聚果糖、聚葡糖糖、菌粉和异构化乳糖，能增殖有益微生物，改善肠道环境，促进消化吸收；通过设洋车前子、山药粉和聚葡糖糖等，可增加饱腹感，减少进食量；通过设洋车前子、燕麦纤维、小麦纤维、苹果纤维等，可调节现代人调节高脂高糖高蛋白的饮食，增加膳食纤维片摄入量，减少脂肪堆积，预防肥胖等功效。
具体实施例
下面将结合本发明实施例，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明的一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有作出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
需要说明，本发明实施例中所有方向性指示(诸如上、下、左、右、前、后……)仅用于解释在某一特定姿态下各部件之间的相对位置关系、运动情况等，如果该特定姿态发生改变时，则该方向性指示也相应地随之改变。
另外，在本发明中如涉及“第一”、“第二”等的描述仅用于描述目的，而不能理解为指示或暗示其相对重要性或者隐含指明所指示的技术特征的数量。由此，限定有“第一”、“第二”的特征可以明示或者隐含地包括至少一个该特征。在本发明的描述中，“多个”的含义是至少两个，例如两个，三个等，除非另有明确具体的限定。
并且，本发明各个实施例之间的技术方案可以相互结合，但是必须是以本领域普通技术人员能够实现为基础，当技术方案的结合出现相互矛盾或无法实现时应当认为这种技术方案的结合不存在，也不在本发明要求的保护范围之内。
下面结合一些实施例与对比例对本发明作进一步说明。以下实施例只是本发明的典型例，本发明的保护范围并不局限于此。
本发明提供的一种酵纤复合营养素粉，所述酵纤复合营养素粉包括主要成分和辅料，所述主要成分包括洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉。
具体地，所述辅料包括复合维生素和矿物质。所述复合维生素包括醋酸维生素A、L-抗坏血酸、胆钙化醇、dl-α-醋酸生育酚和B族维生素。所述B 族维生素包括硝酸硫胺素、核黄素、烟酰胺、D-泛酸钙、盐酸吡哆醇、叶酸、氰钴胺。所述矿物质包括硫酸锌和硫酸镁。所述辅料还包括乙二胺四乙酸铁钠、牛磺酸、聚葡萄糖、乳糖醇和异构化乳糖。
优选地，按质量份数计，所述洋车前子150～200质量份、所述燕麦纤维 150～200质量份、所述小麦纤维150～200质量份、所述小麦苗粉80～150质量份、所述山药粉100～150质量份、所述低聚果糖100～150质量份、所述苹果纤维100～150质量份、所述甜橙水果粉30～50质量份、所述酵母粉30～50质量份和所述菊粉80～150质量份。
优选地，按质量份数计，所述醋酸维生素A为1～5质量份、所述L-抗坏血酸为1～5质量份、所述胆钙化醇为1～5质量份、所述dl-α-醋酸生育酚为1～5质量份和所述B族维生素为7～35质量份、所述硫酸锌为1～5质量份、所述硫酸镁为1～5质量份、所述乙二胺四乙酸铁钠为1～5质量份、所述牛磺酸为1～5质量份和所述聚葡萄糖为1～5质量份、乳糖醇为1～5质量份、异构化乳糖为1～5质量份。
洋车前子中87％是食物纤维，高纤低热量，有助于现代人调节高脂高糖高蛋白的饮食，维护健康；洋车前子少量摄取就能得到饱腹感，吸收、排泄肠内的废物，调整肠内环境，使肠的运动旺盛，增加便量，促进排便，具有美容、减肥效果，并可降低血液中的胆固醇，调节血糖值；洋车前子溶于水大约膨胀50倍，具有极高的膨润性和保水性，可使粪便体积增加且松软，有粘性易成型，洋车前子的保水性是苹果五倍，麦麸的十倍。
燕麦纤维富含大量的水溶性膳食纤维，膳食纤维具有清理肠道垃圾的作用；燕麦中含有的水溶性β-葡聚糖可减缓血液中葡萄糖含量，可以预防和控制肥胖症、糖尿病及心血管疾病。β-葡聚糖具有非常好的保湿功效，可以促进纤维细胞合成胶原蛋白，帮助伤口愈合，具有良好的皮肤修复功能。
小麦纤维是从小麦植株里提取出来的天然原料，具有丰富的膳食纤维含量，拥有降低脂肪、降低热量的生理营养优势，是一种优秀的天然膳食纤维原料。
小麦苗粉含有丰富的植物蛋白质、叶绿素、抗氧化酵素、膳食纤维等多种营养元素。
山药粉中含有蛋白质、糖类、维生素、脂肪、胆碱、淀粉酶等成分，还含有碘、钙、铁、磷等人体不可缺少的无机盐和微量元素；山药粉含有可溶性纤维，食用后就会产生饱胀感，从而控制进食欲望，能推迟胃内食物的排空，控制饭后血糖升高。
低聚果糖为水溶性膳食纤维，长期服用可以降低血清胆固醇，改善脂质代谢，有促进营养吸收、增殖肠道有益菌群、防治腹泻和便秘的作用。
苹果纤维为褐色或红褐色干燥粉末，有苹果特有的甜味、香味和酸味。可以调节肠道功能，增加排便量及大便次数，改善便秘；能调节血脂，增加胆汁的分泌量，降低血清胆固醇；富含铁、锌等微量元素，可使皮肤细润有光泽，起到美容减肥的作用。
聚葡萄糖是一种水溶性膳食纤维，可以补充人体所需的水溶性膳食纤维；聚葡萄糖是有效的益生元，被摄入人体后，在胃肠道上半部分并不被消化，只是到了胃肠道的下半部分被发酵，这有利于肠道有益菌(双歧杆菌、乳杆菌)的繁殖；聚葡萄糖可调节脂类代谢，可在小肠内造成一层膜，并缠裹部分食物脂肪，能有效限制消化道内脂肪的吸收，促进类脂化合物的排泄，增加饱腹感，减少进食量，从而达到调节血脂，减少脂肪堆积，预防肥胖等功效。
甜橙水果粉天然调味剂，含维生素C，具有调味去腥的作用。
在本实施例中，酵母粉为非活性，酵母粉中富含维生素B群，能够协助体内糖类、脂肪、蛋白质代谢以释放能量；酵母粉为可食用的、营养丰富的单细胞微生物，含天然丰富的营养体系，其中，富含多种氨基酸，是优质完全蛋白，有助于人体组织形成和生长。
菊粉在人的肠道能被有益菌利用，特别是能使双歧杆菌增殖5～10倍，为重要的双歧杆菌增殖因子，同时有害菌会显着减少，改善人体菌群分布，促进健康。通过调整肠胃的运动，促进对维生素以及矿物质微量元素的吸收，从而身体健康，体力充沛，反过来促进体内能量的消耗，达到减肥的目的。增强新陈代谢功能，可控制血脂、降低血糖、预防便秘等功效。
醋酸维生素A(维生素A)为脂溶性维生素，吸收和代谢与脂肪关系密切。可保护眼睛不产生视觉障碍，如夜盲症、角膜干燥症，增强眼睛的细菌感染抵抗力；维生素A还是抗氧化剂，为新生细胞成长所需，体内蛋白质没有维生素A的存在，无法被利用，可以减少皮肤细纹，消除老人斑，称为皱纹消除剂。
L-抗坏血酸(维生素C)具有强大抗氧化作用，第一线抗氧化防御机制可以减缓老化，预防生活习惯病；保护血管壁的正常完整性，有预防动脉血管粥状硬化作用，预防坏血症，将三价铁还原成二价铁，促进肠道吸收；维生素C可以促进胶原蛋白的合成，胶原蛋白占人体蛋白质的三分之一，可以减少皱纹、抑制麦拉宁色素的合成，防止肌肤色素沉淀；促进副肾皮质荷尔蒙的合成，舒缓压力。
胆钙化醇(维生素D3)可提高机体对钙、磷的吸收，使血浆钙和血浆磷的水平达到饱和程度。2、促进生长和骨骼钙化，促进牙齿健全；通过肠壁增加磷的吸收，并通过肾小管增加磷的再吸收；维持血液中柠檬酸盐的正常水平；防止氨基酸通过肾脏损失；提高钙、胆碱、必需脂肪酸、磷、维生素A、维生素C的利用吸收。
dl-α-醋酸生育酚(维生素E)为强而有力的抗氧化剂，可以防止脂肪氧化，保护细胞膜，延长细胞寿命，防止老化；与维生素C有相乘作用，维生素C有助其他抗氧化剂作用，加强维生素E的效力；维持血红球细胞膜完整，避免血溶性贫血。
硝酸硫胺素(维生素B1)可促进柠檬酸循环，协助糖类、脂质、碳水化合物的代谢，转换成能量，产生盐酸，参与消化作用，缺乏易致肥胖，慢性疲劳，导致疲劳症状(肩颈僵硬、食欲不振、倦怠症)；维生素B1是正常生长发育、食欲控制及学习能力不可或缺的物质，也是维持肠、胃、心脏等肌肉张力的维生素；维生素B1可以促进循环，帮助血液形成，抗氧化、抗自由基、延缓衰老。
核黄素(维生素B2)与三大营养素的能量代谢相关，尤其是脂质代谢，有助中性脂肪分解，产生成热量，储存为体力；维生素B2有助于蛋白质的代谢，促进细胞合成，有助人体成长；缺乏时会引发口内炎、口角炎、脂漏性皮肤病、脱毛症等皮肤黏膜疾病及成长障碍。
烟酰胺(维生素B3)是重要的酵素辅酶，参与500多种酵素作用，促进新陈代谢，尤其是酒精的代谢，维护肝脏功能；可扩张血管，改善血液循环，健全皮肤的生物合成，被称作“肌肤的维生素”。
D-泛酸钙(维生素B5)是140多种酵素的辅酶，有助于维持各种代谢，荷尔蒙的合成正常运作；维生素B5对于脂肪酸的代谢非常中重要，若缺乏会造成脂肪囤积在体内，泛酸也有助于高密度蛋白质胆固醇的生成；维生素B5 与副肾皮质荷尔蒙相关，具有调整压力耐受性作用。
盐酸吡哆醇(维生素B6)是蛋白质分解与合成的辅酶，有助于蛋白质的合理作用，可以解决水分滞留问题，有消肿作用；与神经传导物质，多巴胺，血清素，GABA(r-胺基丁酸)等生物合成，荷尔蒙作用的调节有关，有助于神经系统稳定，具有减轻经前症候群(PMS)的作用。
叶酸(维生素B9)与B12都有助于红血球的合成，预防贫血；维生素 B9参与蛋白质的代谢，是乳酸菌增殖的因子；维生素B9与B6、B12可降低血液中的同型半胱氨酸含量，降低粥状动脉硬化，避免心血管疾病。
氰钴胺(维生素B12)能够促进红细胞发育成熟，使机体造血功能处于正常状态，可以增加叶酸利用率，预防恶性贫血；维护神经系统健康，预防睡眠障碍，知觉障碍，食欲不振，倦怠感；可促进蛋白质合成，以辅酶的形式存在，促进碳水化合物、脂肪和蛋白质的代谢。
硫酸锌可补充锌元素，锌元素在人体的生长发育、生殖、免疫、内分泌及日常生理过程中都发挥着重要的作用；锌参与多种酶的合成与启动，对蛋白质、核酸合成、肠道蛋白的吸收和消化发挥重要生理功能，能促进生长发育，维持正常食欲及味觉，增强吞噬细胞吞噬能力，趋化活力及杀菌功能。
硫酸镁可补充镁元素，硫酸镁到达肠腔后，具有一定渗透压，使肠内水分不被肠壁吸收，肠内保有大量水分，能机械地刺激肠的蠕动而排便，因此硫酸镁可用于治疗便秘、肠内异常发酵。
乙二胺四乙酸铁钠可改善营养性贫血、营养强化剂。乙二胺四乙酸铁钠是一种重要的螯合剂，可螯合溶液中的金属离子，促进排铅作重金属解毒；可作为稳定剂、凝固剂、抗氧化剂以及防腐剂的使用。
牛磺酸为胆汁的主要成分，能帮助脂肪消化，吸收脂溶性维生素A、D、 E、K，及调节血清中的胆固醇含量；还可缓解焦虑，增加抗压性，避免肠道障碍，念珠菌过度生长。
乳糖醇具有较低的热量，其代谢途径不同于蔗糖，乳糖醇在小肠中不能被消化吸收，而在大肠中被微生物发酵利用并分解出短链脂肪酸及其他发酵产物。乳糖醇释放的纯热量仅为一般糖类的50％，是代替蔗糖低热值保健食品。
异构化乳糖的甜度是蔗糖的0.5倍，是黏度低、热量低、易溶于水、性能稳定、安全性高、使用方便的一种新型功能性双糖，也是一种有特殊保健功能的寡糖。异构化乳糖是一种益生元，具有增殖双歧杆菌、改善肠道环境和提高肠道健康的功能；有促进钙镁吸收、抑制沙门氏菌、降低血糖指数等生理功能。
在本发明中，通过低聚果糖、聚葡糖糖、菌粉和异构化乳糖，能增殖有益微生物，改善肠道环境，促进消化吸收；通过设洋车前子、山药粉和聚葡糖糖等，可增加饱腹感，减少进食量；通过设洋车前子、燕麦纤维、小麦纤维、苹果纤维等，可调节现代人调节高脂高糖高蛋白的饮食，增加膳食纤维片摄入量，减少脂肪堆积，预防肥胖等功效；通过增加水溶性纤维以帮助肠胃功能修复，增强肠道蠕动，促进多余热量和毒素排出。
本发明还提供了一种如上述的酵纤复合营养素粉的制备方法，其特征在于，包括：
步骤一、将洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉过60-80目筛后混合均匀，得混合粉末a；
步骤二、将醋酸维生素A、L-抗坏血酸、胆钙化醇、dl-α-醋酸生育酚和B族维生素过60-80目筛后混合均匀，得混合粉末b；
步骤三、将硫酸锌、硫酸镁和乙二胺四乙酸铁钠分别研磨，过60目筛后混合，搅拌均匀，得混合粉末c；
步骤四、将所述步骤一中制备的混合粉末a、所述步骤二中制备的混合粉末b、所述步骤三中制备的混合粉末c，并取聚葡萄糖、乳糖醇和异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。
下面结合具体实施例，对本发明提供的酵纤复合营养素粉功效进行具体说明。
实施例1
将150g洋车前子、150g燕麦纤维、150g小麦纤维、80g小麦苗粉、100g 山药粉、100g低聚果糖、100g苹果纤维、30g甜橙水果粉、30g酵母粉和80g 菊粉过60-80目筛后混合均匀，得混合粉末a；
将1g醋酸维生素A、1gL-抗坏血酸、1g胆钙化醇、1gdl-α-醋酸生育酚、 1g硝酸硫胺素、1g核黄素、1g烟酰胺、1gD-泛酸钙、1g盐酸吡哆醇、1g叶酸、1g氰钴胺过60-80目筛后混合均匀，得混合粉末b；
将1g硫酸锌、1g硫酸镁和1g乙二胺四乙酸铁钠分别研磨，过60目筛后混合，搅拌均匀，得混合粉末c；
将制备的混合粉末a、混合粉末b、混合粉末c，并取1g聚葡萄糖、1g 乳糖醇和1g异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。
实施例2
将182g洋车前子、177g燕麦纤维、164g小麦纤维、98g小麦苗粉、123g 山药粉、125g低聚果糖、125g苹果纤维、30g甜橙水果粉、30g酵母粉和80g 菊粉过60-80目筛后混合均匀，得混合粉末a；
将2.2g醋酸维生素A、3.4gL-抗坏血酸、2.1g胆钙化醇、3.2gdl-α-醋酸生育酚、3.1g硝酸硫胺素、2.1g核黄素、1.4g烟酰胺、1.9gD-泛酸钙、4.3g 盐酸吡哆醇、4.3g叶酸、2.2g氰钴胺过60-80目筛后混合均匀，得混合粉末b；
将3.4g硫酸锌、2.5g硫酸镁和1.3g乙二胺四乙酸铁钠分别研磨，过60 目筛后混合，搅拌均匀，得混合粉末c；
将制备的混合粉末a、混合粉末b、混合粉末c，并取2.0g聚葡萄糖、2.0g 乳糖醇和1g异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。
实施例3
将182g洋车前子、177g燕麦纤维、164g小麦纤维、98g小麦苗粉、123g 山药粉、125g低聚果糖、125g苹果纤维、30g甜橙水果粉、30g酵母粉和80g 菊粉过60-80目筛后混合均匀，得混合粉末a；
将2.2g醋酸维生素A、3.4gL-抗坏血酸、2.1g胆钙化醇、3.2gdl-α-醋酸生育酚、3.1g硝酸硫胺素、2.1g核黄素、1.4g烟酰胺、1.9gD-泛酸钙、4.3g 盐酸吡哆醇、4.3g叶酸、2.2g氰钴胺过60-80目筛后混合均匀，得混合粉末b；
将3.4g硫酸锌、2.5g硫酸镁和1.3g乙二胺四乙酸铁钠分别研磨，过60 目筛后混合，搅拌均匀，得混合粉末c；
将制备的混合粉末a、混合粉末b、混合粉末c，并取2.0g聚葡萄糖、2.0g 乳糖醇和3g异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。与实施例2不同之处在于，本实施例中3g异构化乳糖为3g。
实施例4
将182g洋车前子、177g燕麦纤维、164g小麦纤维、98g小麦苗粉、123g 山药粉、125g低聚果糖、125g苹果纤维、30g甜橙水果粉、30g酵母粉和80g 菊粉过60-80目筛后混合均匀，得混合粉末a；
将2.2g醋酸维生素A、3.4gL-抗坏血酸、2.1g胆钙化醇、3.2gdl-α-醋酸生育酚、3.1g硝酸硫胺素、2.1g核黄素、1.4g烟酰胺、1.9gD-泛酸钙、4.3g 盐酸吡哆醇、4.3g叶酸、2.2g氰钴胺过60-80目筛后混合均匀，得混合粉末b；
将3.4g硫酸锌、2.5g硫酸镁和1.3g乙二胺四乙酸铁钠分别研磨，过60 目筛后混合，搅拌均匀，得混合粉末c；
将制备的混合粉末a、混合粉末b、混合粉末c，并取2.0g聚葡萄糖、2.0g 乳糖醇和5g异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。与实施例2不同之处在于，本实施例中3g异构化乳糖为5g。
实施例5
将200g洋车前子、200g燕麦纤维、200g小麦纤维、150g小麦苗粉、150g 山药粉、150g低聚果糖、150g苹果纤维、50g甜橙水果粉、30g酵母粉和80g 菊粉过60-80目筛后混合均匀，得混合粉末a；
将5g醋酸维生素A、5gL-抗坏血酸、5g胆钙化醇、5gdl-α-醋酸生育酚、 5g硝酸硫胺素、5g核黄素、5g烟酰胺、5gD-泛酸钙、4.3g盐酸吡哆醇、5g 叶酸、5g氰钴胺过60-80目筛后混合均匀，得混合粉末b；
将5g硫酸锌、5g硫酸镁和5g乙二胺四乙酸铁钠分别研磨，过60目筛后混合，搅拌均匀，得混合粉末c；
将制备的混合粉末a、混合粉末b、混合粉末c，并取5g聚葡萄糖、5g 乳糖醇和5g异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。
随机选择年龄20至40岁无心血管疾病的试用者，分为6组，其中实验组5组，对照组1组，每组女性5人，男性5人，每个实验组每天分别食用上述实施例1至5中制备的所述酵纤复合营养素粉20g，加200毫升温开水冲泡后服用。对照组每天服用淀粉20g，加200毫升温开水冲泡后服用。试用者保持正常饮食，正常活动。对试用者的血糖血脂进行测量，平均结果如下：
通过对照组和实验组进行比对，可以表示，连续服用酵纤复合营养素粉科有效控制血糖血脂；通过对实验组问卷调查，86％的试用者表示取食品量减小，14％试用者表示取食品量无变化。
以上所述仅为本发明的优选实施例，并非因此限制本发明的专利范围，凡是在本发明的发明构思下，利用本发明说明书所作的等效结构变换，或直接/间接运用在其他相关的技术领域均包括在本发明的专利保护范围内。
Claims (9)
1.一种酵纤复合营养素粉，其特征在于，所述酵纤复合营养素粉包括主要成分和辅料，所述主要成分包括洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉。
2.根据权利要求1所述的酵纤复合营养素粉，其特征在于，所述辅料包括复合维生素和矿物质。
3.根据权利要求2所述的酵纤复合营养素粉，其特征在于，所述复合维生素包括醋酸维生素A、L-抗坏血酸、胆钙化醇、dl-α-醋酸生育酚和B族维生素。
4.根据权利要求3所述的酵纤复合营养素粉，其特征在于，所述B族维生素包括硝酸硫胺素、核黄素、烟酰胺、D-泛酸钙、盐酸吡哆醇、叶酸、氰钴胺。
5.根据权利要求3所述的酵纤复合营养素粉，其特征在于，所述矿物质包括硫酸锌和硫酸镁。
6.根据权利要求5所述的酵纤复合营养素粉，其特征在于，所述辅料还包括聚、乙二胺四乙酸铁钠、牛磺酸、葡萄糖、乳糖醇和异构化乳糖。
7.根据权利要求6所述的酵纤复合营养素粉，其特征在于，按质量份数计，所述洋车前子150～200质量份、所述燕麦纤维150～200质量份、所述小麦纤维150～200质量份、所述小麦苗粉80～150质量份、所述山药粉100～150质量份、所述低聚果糖100～150质量份、所述苹果纤维100～150质量份、所述甜橙水果粉30～50质量份、所述酵母粉30～50质量份和所述菊粉80～150质量份。
8.根据权利要求1所述的酵纤复合营养素粉，其特征在于，按质量份数计，所述醋酸维生素A为1～5质量份、所述L-抗坏血酸为1～5质量份、所述胆钙化醇为1～5质量份、所述dl-α-醋酸生育酚为1～5质量份和所述B族维生素为7～35质量份、所述硫酸锌为1～5质量份、所述硫酸镁为1～5质量份、所述乙二胺四乙酸铁钠为1～5质量份、所述牛磺酸为1～5质量份和所述聚葡萄糖为1～5质量份、乳糖醇为1～5质量份、异构化乳糖为1～5质量份。
9.一种如权利要求1至8中任一项所述的酵纤复合营养素粉的制备方法，其特征在于，包括：
步骤一、将洋车前子、燕麦纤维、小麦纤维、小麦苗粉、山药粉、低聚果糖、苹果纤维、甜橙水果粉、酵母粉和菊粉过60-80目筛后混合均匀，得混合粉末a；
步骤二、将醋酸维生素A、L-抗坏血酸、胆钙化醇、dl-α-醋酸生育酚和B族维生素过60-80目筛后混合均匀，得混合粉末b；
步骤三、将硫酸锌、硫酸镁和乙二胺四乙酸铁钠分别研磨，过60目筛后混合，搅拌均匀，得混合粉末c；
步骤四、将所述步骤一中制备的混合粉末a、所述步骤二中制备的混合粉末b、所述步骤三中制备的混合粉末c，并取聚葡萄糖、乳糖醇和异构化乳糖倒入混合机，以500-600转/分的转速混合30-40分钟，得所述酵纤复合营养素粉。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210391800.5A CN114711374A (zh) | 2022-04-14 | 2022-04-14 | 酵纤复合营养素粉及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210391800.5A CN114711374A (zh) | 2022-04-14 | 2022-04-14 | 酵纤复合营养素粉及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN114711374A true CN114711374A (zh) | 2022-07-08 |
Family
ID=82244161
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210391800.5A Pending CN114711374A (zh) | 2022-04-14 | 2022-04-14 | 酵纤复合营养素粉及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114711374A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113907360A (zh) * | 2021-07-30 | 2022-01-11 | 湖南达侑科技有限公司 | 植物甾醇磷脂组合物及其制备方法 |
| CN114747720A (zh) * | 2022-04-14 | 2022-07-15 | 湖南达侑科技有限公司 | 大豆肽复合粉组合物组合粉及其制备方法 |
Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070113460A (ko) * | 2006-05-24 | 2007-11-29 | 주식회사 산테 | 체중조절용 건강식품 조성물 |
| US20150140178A1 (en) * | 2014-08-07 | 2015-05-21 | Mingfu LU | Complete Nutritional Powder and Preparation Method Thereof |
| CN106135797A (zh) * | 2015-04-27 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | 一种有助于调节血糖的营养组合物及其制备方法 |
| CN106579097A (zh) * | 2016-11-08 | 2017-04-26 | 广东正当年生物科技有限公司 | 一种膳食纤维营养代餐粉及其制备方法 |
| CN106605923A (zh) * | 2016-10-12 | 2017-05-03 | 西安源森生物科技有限公司 | 一种复合膳食纤维及其制备方法 |
| CN106666365A (zh) * | 2016-12-21 | 2017-05-17 | 孙中南 | 一种粉剂及其制备方法 |
| CN106954856A (zh) * | 2017-04-27 | 2017-07-18 | 河南佳禾康生物食品科技有限公司 | 一种酵素膳食纤维及其制备工艺 |
| CN107348332A (zh) * | 2017-07-01 | 2017-11-17 | 马南行 | 一种调节基础代谢组合物及其制备方法 |
| CN108294303A (zh) * | 2018-01-30 | 2018-07-20 | 贵州中科金玖生物技术有限公司 | 一种含膳食纤维的全营养配方粉、其制备方法以及其制品 |
| CN109673906A (zh) * | 2018-12-28 | 2019-04-26 | 深圳易生原生物科技有限公司 | 一种复合膳食纤维粉及其制备方法 |
| CN109907328A (zh) * | 2019-03-13 | 2019-06-21 | 杭州上医御本医药保健品科技开发有限公司 | 一种有益于体重控制和降三高的食品配方 |
| CN110663872A (zh) * | 2019-11-15 | 2020-01-10 | 玛士撒拉（上海）医疗科技有限公司 | 一种全营养代餐减肥食品、制备方法及食用方法 |
| CN111084389A (zh) * | 2020-01-20 | 2020-05-01 | 亨美久健康科技(广东)有限公司 | 一种膳食纤维复合粉及其制备方法 |
| CN111493326A (zh) * | 2020-04-28 | 2020-08-07 | 成都尚医信息科技有限公司 | 一种肠内营养食品及其制备方法和应用 |
| CN111543605A (zh) * | 2020-06-03 | 2020-08-18 | 南通大学 | 一种四高或肥胖人群用综合营养粉 |
| CN114747720A (zh) * | 2022-04-14 | 2022-07-15 | 湖南达侑科技有限公司 | 大豆肽复合粉组合物组合粉及其制备方法 |
-
2022
- 2022-04-14 CN CN202210391800.5A patent/CN114711374A/zh active Pending
Patent Citations (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070113460A (ko) * | 2006-05-24 | 2007-11-29 | 주식회사 산테 | 체중조절용 건강식품 조성물 |
| US20150140178A1 (en) * | 2014-08-07 | 2015-05-21 | Mingfu LU | Complete Nutritional Powder and Preparation Method Thereof |
| CN106135797A (zh) * | 2015-04-27 | 2016-11-23 | 青岛贝尔特生物科技有限公司 | 一种有助于调节血糖的营养组合物及其制备方法 |
| CN106605923A (zh) * | 2016-10-12 | 2017-05-03 | 西安源森生物科技有限公司 | 一种复合膳食纤维及其制备方法 |
| CN106579097A (zh) * | 2016-11-08 | 2017-04-26 | 广东正当年生物科技有限公司 | 一种膳食纤维营养代餐粉及其制备方法 |
| CN106666365A (zh) * | 2016-12-21 | 2017-05-17 | 孙中南 | 一种粉剂及其制备方法 |
| CN106954856A (zh) * | 2017-04-27 | 2017-07-18 | 河南佳禾康生物食品科技有限公司 | 一种酵素膳食纤维及其制备工艺 |
| CN107348332A (zh) * | 2017-07-01 | 2017-11-17 | 马南行 | 一种调节基础代谢组合物及其制备方法 |
| CN108294303A (zh) * | 2018-01-30 | 2018-07-20 | 贵州中科金玖生物技术有限公司 | 一种含膳食纤维的全营养配方粉、其制备方法以及其制品 |
| CN109673906A (zh) * | 2018-12-28 | 2019-04-26 | 深圳易生原生物科技有限公司 | 一种复合膳食纤维粉及其制备方法 |
| CN109907328A (zh) * | 2019-03-13 | 2019-06-21 | 杭州上医御本医药保健品科技开发有限公司 | 一种有益于体重控制和降三高的食品配方 |
| CN110663872A (zh) * | 2019-11-15 | 2020-01-10 | 玛士撒拉（上海）医疗科技有限公司 | 一种全营养代餐减肥食品、制备方法及食用方法 |
| CN111084389A (zh) * | 2020-01-20 | 2020-05-01 | 亨美久健康科技(广东)有限公司 | 一种膳食纤维复合粉及其制备方法 |
| CN111493326A (zh) * | 2020-04-28 | 2020-08-07 | 成都尚医信息科技有限公司 | 一种肠内营养食品及其制备方法和应用 |
| CN111543605A (zh) * | 2020-06-03 | 2020-08-18 | 南通大学 | 一种四高或肥胖人群用综合营养粉 |
| CN114747720A (zh) * | 2022-04-14 | 2022-07-15 | 湖南达侑科技有限公司 | 大豆肽复合粉组合物组合粉及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 李文远;冯涛;姚凌云;: "果蔬膳食纤维在肠道菌群调控中的应用研究进展", 中国果菜, no. 06 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113907360A (zh) * | 2021-07-30 | 2022-01-11 | 湖南达侑科技有限公司 | 植物甾醇磷脂组合物及其制备方法 |
| CN114747720A (zh) * | 2022-04-14 | 2022-07-15 | 湖南达侑科技有限公司 | 大豆肽复合粉组合物组合粉及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022016774A1 (zh) | 利于调节肠道、促进消化、改善便秘的组合物及其制备方法 | |
| CN104287049A (zh) | 一种体重管理的代餐蛋白质粉固体饮料 | |
| CN104872504A (zh) | 一种替代日常饮食且营养均衡的代餐粉及其制备方法 | |
| KR101738912B1 (ko) | 비만억제 및 다이어트 조성물 | |
| CN104544432A (zh) | 一种翅果油复合蛋白固体饮料及其制备方法 | |
| CN108719984B (zh) | 一种针对痛风人群的代餐营养棒及其制备方法 | |
| CN114711374A (zh) | 酵纤复合营养素粉及其制备方法 | |
| CN103110861A (zh) | 一种预防婴幼儿上火调节肠胃的颗粒剂及其制备方法 | |
| CN111802476A (zh) | 一种提高儿童睡眠质量的奶粉及其制备方法 | |
| CN111480851A (zh) | 一种改善人体循环的肠道专属活性多肽组合物 | |
| CN112704237A (zh) | 一种植物肽减脂组合物及其食用方法 | |
| CN110140971A (zh) | 一种水溶性膳食纤维 | |
| CN110037113A (zh) | 一种女士瘦身养颜奶粉 | |
| CN102113652A (zh) | 一种适合“五高”代谢综合症人群的特膳挤压米及其制备方法 | |
| CN110574862A (zh) | 一种适用于青少年儿童的营养减肥代餐粉及其制备方法 | |
| CN113170844A (zh) | 一种蔬果纤维营养饮料 | |
| CN112167639A (zh) | 一种双向调节晨起肠道液体平衡的组合物、制备方法及其用途 | |
| CN107802770A (zh) | 平衡代谢系统根治早期ⅱ型糖尿病的中药和保健品 | |
| CN110279050A (zh) | 一种清肠排毒的果蔬酵素饮料及其制备方法 | |
| CN105497106A (zh) | 一种中药复合发酵粉及其制备方法 | |
| KR20060024766A (ko) | 혈중 저분자량질소함유화합물의 농도를 저감시키는질병개선용식품 | |
| CN114747720A (zh) | 大豆肽复合粉组合物组合粉及其制备方法 | |
| CN101716003B (zh) | 膳食纤维系列口服液 | |
| CN115500508A (zh) | 一种阻糖减脂组合物及其制备方法 | |
| CN112690386A (zh) | 一种具有抗氧化及抑菌作用并能增强心脑血管及人体免疫功能的食疗组方 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20220708 |
|
| RJ01 | Rejection of invention patent application after publication |